Can telomere length predict cardiovascular risk?
Spyridopoulos
Ioakim
I
Molecular Cardiology, Department of Internal Medicine III, University of Frankfurt, 60590 Frankfurt, Germany.
Dimmeler
Stefanie
S
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D017035:Pravastatin / Q000627:therapeutic use*; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016615:Telomere / Q000187:drug effects* / Q000502:physiology; D034501:Telomere-Binding Proteins / Q000097:blood / Q000187:drug effects
D000924:Anticholesteremic Agents; D034501:Telomere-Binding Proteins; D017035:Pravastatin